Market Tracker

08/26 5:16pm ET

Sarepta Therapeutics Inc (NASDAQ:SRPT)

26.78
Delayed Data
As of Aug 26
 +1.02 / +3.96%
Today’s Change
8.00
Today|||52-Week Range
41.97
-30.59%
Year-to-Date
Mallinckrodt DMD Drug Gets Fast Track Status in the U.S.
Aug 26 / Zacks.com - Paid Partner Content
3 Biotech Stocks With Explosive Upside Potential
Aug 23 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close25.76
Today’s open25.76
Day’s range25.75 - 27.13
Volume1,840,512
Average volume (3 months)5,939,539
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-53.39%
Earnings growth (this year)+1.43%
Earnings growth (next 5 years)+0.37%
Revenue growth (last year)-87.16%
P/E ratioNM
Price/Sales1,302.11
Price/Book6.18

Competitors

 Today’s
change
Today’s
% change
INVAInnoviva Inc+0.17+1.52%
DEPODepomed Inc-0.07-0.35%
SAGESAGE Therapeutics In...+1.16+3.10%
LCILannett Company Inc-0.60-1.72%
Data as of 4:01pm ET, 08/26/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$1.28
Annual revenue (last year)$1.3M
Annual profit (last year)-$220.0M
Net profit margin-17,560.26%

Profile

Sector
Health Technology
Industry
Biotechnology
Senior VP, Chief Executive &
Medical Officer
Edward M. Kaye
Head-Operations &
Vice President
Gavin T. Malenfant
Corporate headquarters
Cambridge, Massachusetts

Forecasts